TG Therapeutics, Inc. (TGTX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for TG Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 9.62x | 187.06x | 191.33x | -7.16x | -7.22x | -21.47x |
| P/B Ratio | 6.64x | 19.67x | 15.11x | 27.34x | 10.59x | 11.55x |
| P/S Ratio | 6.98x | 13.29x | 10.38x | 575.19x | 375.58x | 39471.44x |
| Profitability | ||||||
| Gross Margin | 83.7% | 88.3% | 94.0% | 90.5% | 88.2% | 100.0% |
| Operating Margin | 20.0% | 12.7% | 8.8% | -7839.0% | -5154.3% | -179996.1% |
| Net Margin | 72.6% | 7.1% | 5.4% | -8036.3% | -5204.1% | -183803.3% |
| EBITDA Margin | 21.8% | 15.2% | 11.2% | -7651.9% | -5112.4% | -179393.4% |
| Liquidity | ||||||
| Current Ratio | 4.10x | 6.25x | 5.92x | 3.16x | 5.06x | 6.99x |
| Quick Ratio | 3.29x | 5.03x | 5.18x | 3.16x | 5.06x | 6.99x |
| Leverage | ||||||
| Debt/Equity | 0.40x | 1.14x | 0.69x | 1.42x | 0.33x | 0.08x |
YoY = year-over-year change. Source: FMP..